Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 10Terminated 6Withdrawn 2Unknown 2Active not recruiting 2Suspended 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Carcinoma, Non-Small-Cell Lung 20Prostatic Neoplasms 19Carcinoma, Hepatocellular 15Brain Neoplasms 12Breast Neoplasms 10Pancreatic Neoplasms 9Neoplasm Metastasis 9Lung Neoplasms 5Neoplasms 4Recurrence 3Colorectal Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neuroma, Acoustic 2NSCLC 2Liver Neoplasms 2Head and Neck Neoplasms 2Glioblastoma 2Esophageal Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer 1Stage IA - IB Non Small Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Spine Metastasis 1Spinal Neoplasms 1Spinal Bone Metastases 1Solid Tumor 1Sarcoma 1Rare Diseases 1Radiotherapy 1

Interventions

Temozolomide 44Radiotherapy 16Bevacizumab 9Surgical Procedures, Operative 5Carmustine 5Lomustine 4Drug Therapy 4pembrolizumab 3Sunitinib 3Standard of Care 3Radiation 3Procarbazine 3Irinotecan 3Granulocyte-Macrophage Colony-Stimulating Factor 3Chlorotoxin 3Carboplatin 3Blood Specimen Collection 3tislelizumab 2fludarabine 2camrelizumab 2Radiosurgery 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2Hyperbaric Oxygenation 2Ethanol 2Cyclophosphamide 2Chemotherapy, Adjuvant 2CT-322 2Bortezomib 2Aminolevulinic Acid 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Glioblastoma × Radiosurgery × Clear all
NCT04671459 2023-06-28

TaRRGET

Prof. Franciszek Lukaszczyk Memorial Oncology Center

Phase 2 Unknown
40 enrolled
CNS

Glioblastoma, Recurrence

NCT05131711 2021-11-23

CSREIG

Beijing Tiantan Hospital

Phase 1/2 Unknown
60 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡